REQUEST A DEMO
Total
USD $0.00
Search more companies

Etela Alborz Investment Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing | Other Financial Investment Activities
Full name: Etela Alborz Investment Company Public Joint Stock Profile Updated: March 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Main Activity of the Company is Investment in Shared including Shares of the Company, units of Investment funds or other Securities with Voting rights of Companies, institutions or investment funds with the purpose of gaining profit.
The Company was Established as a Private Joint Stock Company under name Sanaye Bonyad Panzdah Khordad Investment Company Private joint stockand registered under registration number 70764 on 10 August 1988.
The Company changed its name to be Etela Alborz Investment company public joint stock on 4 December 2004.
The Company changed its legal form to be private Company on 22 May 2010.
then it changed its legal form again to be public joint stock company 25 January 2014.
The Company was listed in Iran Fara Bourse on 8 December 2013.
Tthe company changed it s year end to be 21 December 2019 .
Mission
Establishment and management of specialized and non-managerial portfolio in pharmaceutical industry with a synergistic approach
Executive arm of Alborz Investment Company in the capital market
Active presence in capital market and using the opportunities in the Stock Exchange.
Vision
The goal of the company is to become the top investment company in Iran

Headquarters
Khaled Islambouli St. (Ministers) Above Shahid Beheshti St, 3Rd Alley, No. 30 - Second Floor
Tehran; Tehran; Postal Code: 1513633713

Contact Details: Purchase the Etela Alborz Investment Company Public Joint Stock report to view the information.

Website: http://etelainvest.ir

Basic Information
Total Employees:
Purchase the Etela Alborz Investment Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Etela Alborz Investment Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Etela Alborz Investment Company Public Joint Stock report to view the information.
Incorporation Date:
1988
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
52%
Purchase this report to view the information.
1%
Purchase this report to view the information.
1%
Purchase this report to view the information.
1%
Subsidiaries
Sobhan Darou Public Joint Stock Company
2.7%
Sobhan Oncology Pharmaceutical Company Public Joint Stock
2%
Sobhan Pharmaceutical Group Company Public Joint Stock
1%
Company Performance
Financial values in the chart are available after Etela Alborz Investment Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Total operating revenue
47.34%
Operating profit (EBIT)
-84.9%
Net Profit (Loss) for the Period
42.03%
Total assets
54.07%
Total equity
45.54%
Return on Equity (ROE)
-1.13%
Quick Ratio
-1.86%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?